Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis
  Free Subscription

Articles published in
Clin Infect Dis
    September 2025
  1. LO RE V 3RD, Bhattacharya D, Price JC, Aronsohn A, et al
    State-of-the-Art Review: Hepatitis C.
    Clin Infect Dis. 2025;81:e15-e26.
    >> Share

  2. LO RE V 3RD, Bhattacharya D, Price J, Aronsohn A, et al
    Executive Summary: State-of-the-Art Review: Hepatitis C.
    Clin Infect Dis. 2025;81:217-219.
    >> Share

    August 2025
  3. CHAPPELL CA, Brooks KM, Kiser JJ, Klein B, et al
    Sofosbuvir/Velpatasvir Concentrations in the Breastmilk of Postpartum Women with Opioid Use Disorder Receiving Treatment for Hepatitis C Virus: a pharmacokinetic study.
    Clin Infect Dis. 2025 Aug 7:ciaf443. doi: 10.1093.
    >> Share

    July 2025
  4. KIM AY, Kang M, Umbleja T, Nunes EP, et al
    Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.
    Clin Infect Dis. 2025 Jul 30:ciaf305. doi: 10.1093.
    >> Share

  5. BERENGUER J, Fanciulli C, Arcos MM, Vivancos MJ, et al
    Trends in HCV Infection Prevalence Among People with HIV in Spain Over Two Decades (2002-2023).
    Clin Infect Dis. 2025 Jul 24:ciaf407. doi: 10.1093.
    >> Share

  6. WOODHOUSE EW, Henson JB, Yarrington ME, Lushniak L, et al
    Take It Off the Back Burner-Missed Opportunities to Treat Hepatitis C Virus (HCV) Inpatients.
    Clin Infect Dis. 2025 Jul 23:ciaf303. doi: 10.1093.
    >> Share

  7. GREBELY J
    Right test for the right patient in the right setting: Enhancing testing and treatment for hepatitis C infection among people who inject drugs.
    Clin Infect Dis. 2025 Jul 15:ciaf367. doi: 10.1093.
    >> Share

  8. ZHU L, Furukawa NW, Thompson WW, Reitsma MB, et al
    Potential impact of frequent testing for hepatitis C virus among people who inject drugs toward hepatitis C elimination in the United States.
    Clin Infect Dis. 2025 Jul 15:ciaf368. doi: 10.1093.
    >> Share

  9. PRASAD M, Sandoval GJ, Saade GR, Hughes BL, et al
    Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus.
    Clin Infect Dis. 2025 Jul 14:ciaf266. doi: 10.1093.
    >> Share

  10. GRIFFIN S, Asselin J, Wilkinson AL, Traeger MW, et al
    The hepatitis C cascade of care for opioid agonist therapy recipients in Australia.
    Clin Infect Dis. 2025 Jul 9:ciaf352. doi: 10.1093.
    >> Share

    May 2025
  11. AUDSLEY J, Avihingsanon A, Li X, Edwards R, et al
    Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and chronic HBV co-infection.
    Clin Infect Dis. 2025 May 31:ciaf281. doi: 10.1093.
    >> Share

  12. HALL EW, Sandul AL, Kamili S, Cartwright EJ, et al
    Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults.
    Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093.
    >> Share

  13. KU JH, Gu YM, Hoke CF, Tseng HF, et al
    Screening and vaccination rates for tetanus, hepatitis A, and hepatitis B among individuals with substance use disorders who are hospitalized in an integrated U.S. health system.
    Clin Infect Dis. 2025 May 20:ciaf251. doi: 10.1093.
    >> Share

    April 2025
  14. SHEMUEL J, Krawiec A, Kalauokalani D, Lucas KD, et al
    A Case-Control Study of Hepatitis C Virus Re-infection in Incarcerated Patients in California Receiving Medication for Opioid Use Disorder.
    Clin Infect Dis. 2025 Apr 15:ciaf192. doi: 10.1093.
    >> Share

  15. THOMAS AM, Litwin AH, Tsui JI, Sprecht-Walsh S, et al
    Retreatment of Hepatitis C Virus Among People Who Inject Drugs.
    Clin Infect Dis. 2025 Apr 15:ciaf082. doi: 10.1093.
    >> Share

  16. CARSON JM, Dore GJ
    Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject Drugs.
    Clin Infect Dis. 2025 Apr 15:ciaf083. doi: 10.1093.
    >> Share

  17. TOY M, Hutton D, Teshale E, Thompson WW, et al
    Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States.
    Clin Infect Dis. 2025 Apr 8:ciaf181. doi: 10.1093.
    >> Share

    February 2025
  18. AZZELLINO G, Ginaldi L, De Martinis M
    A Biosocial Roadmap to Tackle the Burden of Hepatitis C Virus Infections That Ensures Health Equity for All.
    Clin Infect Dis. 2025 Feb 12:ciae623. doi: 10.1093.
    >> Share

    January 2025
  19. SERUMONDO J, Barebwanuwe P, Sheferaw ED, Iyonizera J, et al
    Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen for Hepatitis C: Evaluation of a Government Program in Rwanda.
    Clin Infect Dis. 2025 Jan 29:ciae637. doi: 10.1093.
    >> Share

  20. BARRE T, Ramier C, Wittkop L, Sogni P, et al
    Low CD4 cell count is associated with post-hepatitis C virus cure mortality in people living with HIV (ANRS CO13 HEPAVIH cohort).
    Clin Infect Dis. 2025 Jan 15:ciaf016. doi: 10.1093.
    >> Share

  21. MATELSKI A, Gregoire B, Beste LA, Varley CD, et al
    Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of U.S. Veterans.
    Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093.
    >> Share

  22. HUANG YS, Sun HY, Ho SY, Lin KY, et al
    Incidence and outcome of hepatitis D virus infection in people with HIV in the era of tenofovir-containing antiretroviral therapy.
    Clin Infect Dis. 2025 Jan 2:ciae655. doi: 10.1093.
    >> Share

    December 2024
  23. HAN WM, Solomon S, Smeaton L, Avihingsanon A, et al
    Reinfection and resistance associated substitutions following a minimal monitoring approach for HCV treatment in MINMON trial.
    Clin Infect Dis. 2024 Dec 20:ciae627. doi: 10.1093.
    >> Share

  24. CHAPPELL CA, Kiser JJ, Brooks KM, Randolph R, et al
    Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus.
    Clin Infect Dis. 2024 Dec 17:ciae595. doi: 10.1093.
    >> Share

    November 2024
  25. SEAMAN A, Cook R, Leichtling G, Herink MC, et al
    Peer-assisted telemedicine for hepatitis C in people who use drugs: A randomized controlled trial.
    Clin Infect Dis. 2024 Nov 27:ciae520. doi: 10.1093.
    >> Share

  26. AKIYAMA MJ, Thornton K, Voyles N, Vincent L, et al
    Meeting People Where They Are: The Roles of Peer Navigation and Telemedicine for HCV Elimination.
    Clin Infect Dis. 2024 Nov 27:ciae521. doi: 10.1093.
    >> Share

  27. PERERA H, Keeshan A, Imsirovic H, Patern J, et al
    Rapid HCV Engagement and Treatment in Hospitalized Patients.
    Clin Infect Dis. 2024 Nov 21:ciae574. doi: 10.1093.
    >> Share

  28. EPSTEIN RL, Munroe S, Taylor LE, Duryea PR, et al
    Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study.
    Clin Infect Dis. 2024 Nov 13:ciae485. doi: 10.1093.
    >> Share

    October 2024
  29. INZAULE S, Easterbrook P, Latona A, Ford NP, et al
    Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2024 Oct 3:ciae431. doi: 10.1093.
    >> Share

  30. BIONDI BE, Munroe S, Lavarin C, Curtis MR, et al
    Racial and Ethnic Disparities in Hepatitis C Care in Reproductive-Aged Women With Opioid Use Disorder.
    Clin Infect Dis. 2024 Oct 2:ciae426. doi: 10.1093.
    >> Share

    September 2024
  31. MARTIN-CARMONA J, Corma-Gomez A, Tellez F, Arenga-Barrios D, et al
    No impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response.
    Clin Infect Dis. 2024 Sep 18:ciae473. doi: 10.1093.
    >> Share

  32. MACISAAC MB, Papaluca T, McDonald L, Craigie A, et al
    Long-term outcomes of a decentralized, nurse-led, statewide model of care for hepatitis C among people in prison in Victoria, Australia.
    Clin Infect Dis. 2024 Sep 16:ciae471. doi: 10.1093.
    >> Share

    July 2024
  33. FRIEDMAN JR, Abramovitz D, Skaathun B, Rangel G, et al
    Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
    Clin Infect Dis. 2024 Jul 30:ciae372. doi: 10.1093.
    >> Share

  34. FIERER DS, Carollo JR, Rodriguez-Caprio G, Radix A, et al
    Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City.
    Clin Infect Dis. 2024 Jul 18:ciae297. doi: 10.1093.
    >> Share

    June 2024
  35. RUSS RK, Vandehei HM, Golovkina MI, Mogallapalli H, et al
    Hepatitis B-CpG vaccine series for healthcare workers who are hepatitis B vaccine nonresponders.
    Clin Infect Dis. 2024 Jun 17:ciae320. doi: 10.1093.
    >> Share

  36. MIDGARD H, Malme KB, Finbraten AK, Dalgard O, et al
    Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins?
    Clin Infect Dis. 2024 Jun 2:ciae298. doi: 10.1093.
    >> Share

    May 2024
  37. PAN CQ, Zhu L, Yu AS, Zhao Y, et al
    Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2024 May 28:ciae288. doi: 10.1093.
    >> Share

  38. LO RE V 3RD, Price JC, Schmitt S, Terrault N, et al
    The Obstacle is the Way: Finding a Path to Hepatitis C Elimination.
    Clin Infect Dis. 2024 May 16:ciae231. doi: 10.1093.
    >> Share

  39. ZHANG HL, Mock M, Bushman L, Anderson PL, et al
    Cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatitis B co-infection with differential viral suppression.
    Clin Infect Dis. 2024 May 3:ciae241. doi: 10.1093.
    >> Share

    April 2024
  40. HOOD RB, Norris AH, Shoben A, Miller WC, et al
    Forecasting Hepatitis C Virus Status for Children in the United States: A Modeling Study.
    Clin Infect Dis. 2024 Apr 17:ciae157. doi: 10.1093.
    >> Share

  41. CAFARDI JM, Lin HT, Lange L, Kelley L, et al
    Vertical Transmission of Hepatitis C Virus Among Women with a History of Injection Opioid Use.
    Clin Infect Dis. 2024 Apr 5:ciae177. doi: 10.1093.
    >> Share

  42. SU WJ, Chen HL, Chen SF, Liu YL, et al
    Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing.
    Clin Infect Dis. 2024 Apr 2:ciae176. doi: 10.1093.
    >> Share

    March 2024
  43. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
    Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
    Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
    >> Share

  44. GREBELY J
    Point-of-care testing for hepatitis C infection: A critical building block for the foundation to achieve elimination.
    Clin Infect Dis. 2024 Mar 21:ciae156. doi: 10.1093.
    >> Share

  45. MCCARTNEY EM, Ralton L, Dawe J, Richmond J, et al
    Point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities - the PROMPt Study.
    Clin Infect Dis. 2024 Mar 21:ciae155. doi: 10.1093.
    >> Share

    February 2024

  46. Correction to: Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020.
    Clin Infect Dis. 2024 Feb 23:ciad783. doi: 10.1093.
    >> Share

    January 2024
  47. LITWIN AH, Akiyama MJ
    US Veterans Health Administration Hepatitis C Virus (HCV) Program - A Model for National HCV Elimination though Patient-Centered Medical Homes.
    Clin Infect Dis. 2024 Jan 27:ciae028. doi: 10.1093.
    >> Share

  48. VARLEY CD, Lowy E, Cartwright EJ, Morgan TR, et al
    Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
    Clin Infect Dis. 2024 Jan 27:ciae025. doi: 10.1093.
    >> Share

    November 2023
  49. VINIKOOR MJ, Hamusonde K, Muula G, Asombang M, et al
    Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia.
    Clin Infect Dis. 2023 Nov 24:ciad654. doi: 10.1093.
    >> Share

  50. MIDGARD H, Malme KB, Pihl CM, Berg-Pedersen RM, et al
    Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial.
    Clin Infect Dis. 2023 Nov 22:ciad711. doi: 10.1093.
    >> Share

  51. ROWAN SE, Wyles DL
    Don't put off until tomorrow what you can do today: Hospital admissions as an opportunity to treat hepatitis C.
    Clin Infect Dis. 2023 Nov 22:ciad712. doi: 10.1093.
    >> Share

    October 2023
  52. WONG RJ, Yang Z, Cheung R
    Disparities in Antiviral Treatment among Adults with Hepatitis B Cirrhosis: An Analysis of the National Veterans Affairs Cohort.
    Clin Infect Dis. 2023 Oct 9:ciad617. doi: 10.1093.
    >> Share

    September 2023
  53. YANG J, Lo NC, Dankwa EA, Donnelly CA, et al
    Determining herd immunity thresholds for hepatitis A virus transmission to inform vaccination strategies among people who inject drugs in 16 U.S. States.
    Clin Infect Dis. 2023 Sep 21:ciad552. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016